Fuan Pharmaceutical Group Co Total Liabilities
Fuan Pharmaceutical Group Co total liabilities. Based on the latest financial reports, Fuan Pharmaceutical Group Co (300194) has total liabilities worth CN¥1.21 Billion CNY (≈ $176.74 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Fuan Pharmaceutical Group Co asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Fuan Pharmaceutical Group Co (2007–2025)
Total liabilities of Fuan Pharmaceutical Group Co from 2007 to 2025. This chart illustrates how Fuan Pharmaceutical Group Co's total liabilities have evolved over time, based on quarterly financial data. Explore 300194 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Fuan Pharmaceutical Group Co Competitors by Total Liabilities
The table below lists competitors of Fuan Pharmaceutical Group Co ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zhejiang Zomax Transmission
SHG:603767
|
China | CN¥290.62 Million |
|
Weikeng Industrial Co Ltd
TW:3033
|
Taiwan | NT$45.55 Billion |
|
Ningxia Xinri Hengli Steel Wire Rope Co Ltd
SHG:600165
|
China | CN¥1.14 Billion |
|
Qfin Holdings, Inc.
NASDAQ:QFIN
|
USA | $28.32 Billion |
|
Zhejiang Chunhui Intelligent Control Co. Ltd.
SHE:300943
|
China | CN¥248.56 Million |
|
Beijing Asiacom Information Technology Co.Ltd
SHE:301085
|
China | CN¥718.92 Million |
|
Zee Entertainment Enterprises Limited
NSE:ZEEL
|
India | Rs24.87 Billion |
|
Jenkem Technology Co Ltd
SHG:688356
|
China | CN¥81.71 Million |
Liability Composition Analysis (2007–2025)
This chart breaks down Fuan Pharmaceutical Group Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 300194 total asset value.
Liquidity & Leverage Metrics
Fuan Pharmaceutical Group Co Total Liabilities Ratios Explained
Fuan Pharmaceutical Group Co total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.25 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Fuan Pharmaceutical Group Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Fuan Pharmaceutical Group Co (2007–2025)
The table below shows the annual total liabilities of Fuan Pharmaceutical Group Co from 2007 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.40 Billion ≈ $204.56 Million |
-11.55% |
| 2024-12-31 | CN¥1.58 Billion ≈ $231.27 Million |
-13.50% |
| 2023-12-31 | CN¥1.83 Billion ≈ $267.38 Million |
-5.40% |
| 2022-12-31 | CN¥1.93 Billion ≈ $282.64 Million |
+4.94% |
| 2021-12-31 | CN¥1.84 Billion ≈ $269.34 Million |
+29.83% |
| 2020-12-31 | CN¥1.42 Billion ≈ $207.46 Million |
+89.89% |
| 2019-12-31 | CN¥746.59 Million ≈ $109.25 Million |
+24.72% |
| 2018-12-31 | CN¥598.62 Million ≈ $87.60 Million |
+15.51% |
| 2017-12-31 | CN¥518.24 Million ≈ $75.83 Million |
+19.41% |
| 2016-12-31 | CN¥434.00 Million ≈ $63.51 Million |
+26.56% |
| 2015-12-31 | CN¥342.91 Million ≈ $50.18 Million |
+175.02% |
| 2014-12-31 | CN¥124.69 Million ≈ $18.25 Million |
-9.95% |
| 2013-12-31 | CN¥138.47 Million ≈ $20.26 Million |
+64.44% |
| 2012-12-31 | CN¥84.20 Million ≈ $12.32 Million |
-32.47% |
| 2011-12-31 | CN¥124.69 Million ≈ $18.25 Million |
+91.57% |
| 2010-12-31 | CN¥65.09 Million ≈ $9.52 Million |
-41.00% |
| 2009-12-31 | CN¥110.31 Million ≈ $16.14 Million |
+20.13% |
| 2008-12-31 | CN¥91.83 Million ≈ $13.44 Million |
+26.53% |
| 2007-12-31 | CN¥72.58 Million ≈ $10.62 Million |
-- |
About Fuan Pharmaceutical Group Co
Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, research and develops, produces, and sells chemical drugs in the People's Republic of China and internationally. It offers APIs; intermediates; and FDFs, such as anti-tumor, specialty drugs, antibiotics, as well as freeze-drying preparation for injection. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) … Read more